vs
CASELLA WASTE SYSTEMS INC（CWST）とRevvity（RVTY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revvityの直近四半期売上が大きい（$772.1M vs $469.1M、CASELLA WASTE SYSTEMS INCの約1.6倍）。Revvityの純利益率が高く（12.7% vs -0.5%、差は13.3%）。CASELLA WASTE SYSTEMS INCの前年同期比売上増加率が高い（9.7% vs 5.9%）。Revvityの直近四半期フリーキャッシュフローが多い（$161.8M vs $39.3M）。過去8四半期でCASELLA WASTE SYSTEMS INCの売上複合成長率が高い（17.3% vs 9.0%）
カセラ・ウェイスト・システムズ（Casella Waste Systems, Inc.）は米国バーモント州ラトランドに本拠を置く廃棄物管理企業です。1975年にトラック1台から創業し、現在は地域密着型の垂直統合固形廃棄物サービス事業者として、一般家庭、企業、自治体、産業顧客向けに固形廃棄物の収集・処分、移送、リサイクル、有機性廃棄物処理などのサービスを提供しています。
レブィティ（Revvity, Inc.）は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
CWST vs RVTY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $469.1M | $772.1M |
| 純利益 | $-2.5M | $98.4M |
| 粗利率 | 33.3% | — |
| 営業利益率 | 2.5% | 14.5% |
| 純利益率 | -0.5% | 12.7% |
| 売上前年比 | 9.7% | 5.9% |
| 純利益前年比 | -151.5% | 3.9% |
| EPS（希薄化後） | $-0.04 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $469.1M | $772.1M | ||
| Q3 25 | $485.4M | $698.9M | ||
| Q2 25 | $465.3M | $720.3M | ||
| Q1 25 | $417.1M | $664.8M | ||
| Q4 24 | $427.5M | $729.4M | ||
| Q3 24 | $411.6M | $684.0M | ||
| Q2 24 | $377.2M | $691.7M | ||
| Q1 24 | $341.0M | $649.9M |
| Q4 25 | $-2.5M | $98.4M | ||
| Q3 25 | $10.0M | $46.7M | ||
| Q2 25 | $5.2M | $53.9M | ||
| Q1 25 | $-4.8M | $42.2M | ||
| Q4 24 | $4.9M | $94.6M | ||
| Q3 24 | $5.8M | $94.4M | ||
| Q2 24 | $7.0M | $55.4M | ||
| Q1 24 | $-4.1M | $26.0M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 35.0% | 53.6% | ||
| Q2 25 | 33.8% | 54.5% | ||
| Q1 25 | 32.8% | 56.5% | ||
| Q4 24 | 33.2% | — | ||
| Q3 24 | 35.1% | 56.3% | ||
| Q2 24 | 35.4% | 55.7% | ||
| Q1 24 | 32.3% | 54.6% |
| Q4 25 | 2.5% | 14.5% | ||
| Q3 25 | 6.1% | 11.7% | ||
| Q2 25 | 4.1% | 12.6% | ||
| Q1 25 | 0.8% | 10.9% | ||
| Q4 24 | 4.3% | 16.3% | ||
| Q3 24 | 5.9% | 14.3% | ||
| Q2 24 | 6.1% | 12.4% | ||
| Q1 24 | 2.0% | 6.8% |
| Q4 25 | -0.5% | 12.7% | ||
| Q3 25 | 2.1% | 6.7% | ||
| Q2 25 | 1.1% | 7.5% | ||
| Q1 25 | -1.2% | 6.4% | ||
| Q4 24 | 1.1% | 13.0% | ||
| Q3 24 | 1.4% | 13.8% | ||
| Q2 24 | 1.9% | 8.0% | ||
| Q1 24 | -1.2% | 4.0% |
| Q4 25 | $-0.04 | $0.86 | ||
| Q3 25 | $0.16 | $0.40 | ||
| Q2 25 | $0.08 | $0.46 | ||
| Q1 25 | $-0.08 | $0.35 | ||
| Q4 24 | $0.08 | $0.77 | ||
| Q3 24 | $0.10 | $0.77 | ||
| Q2 24 | $0.12 | $0.45 | ||
| Q1 24 | $-0.07 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $123.8M | $919.9M |
| 総負債低いほど良い | $1.1B | — |
| 株主資本純資産 | $1.6B | $7.3B |
| 総資産 | $3.3B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.72× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.8M | $919.9M | ||
| Q3 25 | $192.7M | $931.4M | ||
| Q2 25 | $217.8M | $991.8M | ||
| Q1 25 | $267.7M | $1.1B | ||
| Q4 24 | $358.3M | $1.2B | ||
| Q3 24 | $519.0M | $1.2B | ||
| Q2 24 | $208.5M | $2.0B | ||
| Q1 24 | $189.5M | $1.7B |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $976.6M | — | ||
| Q1 24 | $980.9M | — |
| Q4 25 | $1.6B | $7.3B | ||
| Q3 25 | $1.6B | $7.4B | ||
| Q2 25 | $1.6B | $7.6B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.6B | $7.7B | ||
| Q3 24 | $1.5B | $7.9B | ||
| Q2 24 | $1.0B | $7.9B | ||
| Q1 24 | $1.0B | $7.8B |
| Q4 25 | $3.3B | $12.2B | ||
| Q3 25 | $3.3B | $12.1B | ||
| Q2 25 | $3.3B | $12.4B | ||
| Q1 25 | $3.2B | $12.4B | ||
| Q4 24 | $3.2B | $12.4B | ||
| Q3 24 | $3.1B | $12.8B | ||
| Q2 24 | $2.5B | $13.4B | ||
| Q1 24 | $2.5B | $13.4B |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 0.96× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $96.6M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $39.3M | $161.8M |
| FCFマージンFCF / 売上 | 8.4% | 21.0% |
| 設備投資強度設備投資 / 売上 | 12.2% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | — | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $84.7M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $96.6M | $182.0M | ||
| Q3 25 | $93.6M | $138.5M | ||
| Q2 25 | $89.5M | $134.3M | ||
| Q1 25 | $50.1M | $128.2M | ||
| Q4 24 | $109.8M | $174.2M | ||
| Q3 24 | $91.8M | $147.9M | ||
| Q2 24 | $72.1M | $158.6M | ||
| Q1 24 | $7.7M | $147.6M |
| Q4 25 | $39.3M | $161.8M | ||
| Q3 25 | $27.6M | $120.0M | ||
| Q2 25 | $23.1M | $115.5M | ||
| Q1 25 | $-5.4M | $112.2M | ||
| Q4 24 | $32.9M | $149.8M | ||
| Q3 24 | $40.4M | $125.6M | ||
| Q2 24 | $27.5M | $136.6M | ||
| Q1 24 | $-22.6M | $129.7M |
| Q4 25 | 8.4% | 21.0% | ||
| Q3 25 | 5.7% | 17.2% | ||
| Q2 25 | 5.0% | 16.0% | ||
| Q1 25 | -1.3% | 16.9% | ||
| Q4 24 | 7.7% | 20.5% | ||
| Q3 24 | 9.8% | 18.4% | ||
| Q2 24 | 7.3% | 19.7% | ||
| Q1 24 | -6.6% | 20.0% |
| Q4 25 | 12.2% | 2.6% | ||
| Q3 25 | 13.6% | 2.6% | ||
| Q2 25 | 14.3% | 2.6% | ||
| Q1 25 | 13.3% | 2.4% | ||
| Q4 24 | 18.0% | 3.4% | ||
| Q3 24 | 12.5% | 3.3% | ||
| Q2 24 | 11.8% | 3.2% | ||
| Q1 24 | 8.9% | 2.7% |
| Q4 25 | — | 1.85× | ||
| Q3 25 | 9.37× | 2.97× | ||
| Q2 25 | 17.19× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 22.51× | 1.84× | ||
| Q3 24 | 15.91× | 1.57× | ||
| Q2 24 | 10.29× | 2.87× | ||
| Q1 24 | — | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CWST
| Transferred Over Time | $120.9M | 26% |
| Resource Solutions Region | $92.9M | 20% |
| Collection | $90.9M | 19% |
| Mid Atlantic Region | $89.6M | 19% |
| National Accounts | $60.9M | 13% |
| Landfill Revenue | $8.3M | 2% |
| Processing Services | $2.1M | 0% |
| Transportation | $1.4M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
